Raanana, Israel - Polyrizon Ltd. (NASDAQ:PLRZ), a biotech firm in the development stage, has filed a divisional patent application in Israel for its Trap & Target (NYSE:TGT) (T&T) platform technology.

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a ...

People in England with a severe dust mite allergy are set to be offered a daily pill on the NHS, it has been announced today (Thursday January 30), as part of a big shake up.

Officials installed the stations as part of a pilot program on Monday at the Boston and Springfield RMVs, as well as MassDOT ...